Screening and identification of key biomarkers in nasopharyngeal carcinoma: evidence from bioinformatic analysis
While it has been postulated that these two actions are inextricably linked more recent data shows they can indeed be divorced which opens the opportunity for tailored pharmacology that provide food intake reduction without the adverse events typically associated with GLP-1R agonism
Affecting more than 10 million people worldwide, its incidence is expected to double by 2040 due to population aging and improved survival rates (WHO, 2020
As we get older, we make less catalase
In recent years, an increasing number of previously unknown molecular markers specific to distinct islet cell types have been described
The enzyme, HMG-CoA reductase, catalyses the key reaction in this pathway and is the site of action for statins